Literature DB >> 26602741

Long-term donor-site morbidity after vascularized free fibula flap harvesting: Clinical and gait analysis.

Damien Feuvrier1, Yoshimasa Sagawa2, Samuel Béliard3, Julien Pauchot4, Pierre Decavel2.   

Abstract

The aim of this study was to determine the clinical morbidity and changes in gait temporal spatial parameters after harvesting of a vascularized free fibula flap. This study included 11 patients (mean age: 52 ± 17 years) and 11 healthy controls (mean age: 50 ± 14 years). The patients were assessed between 5 and 104 months post surgery. The study consisted of a subjective functional evaluation with two validated clinical scores (Kitaoka Score and Point Evaluation System (PES) score), clinical and neurological examination of the legs, and evaluation of gait temporal spatial parameters while walking at a comfortable speed. The mean functional Kitaoka score was 78/100, and the mean PES score of 12.18 was considered average. At the time of the review, five patients had sensory disorders, two had toe deformities, and eight had pain at the donor site. The gait analysis showed that the patient's comfortable walking speed was significantly lower in comparison to that of the controls, and that stride length and cadence were reduced. In addition, most of the gait-specific parameters were significantly different. The donor leg displayed greater variability during walking. To reduce the risk of falling, this study revealed that the patients' gait pattern had changed as they took a more cautious approach during walking. Early rehabilitation is expected to help improve and/or restore the physical abilities of patients after harvesting of the vascularized free fibula flap.
Copyright © 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Donor site morbidity; Gait analysis; Head reconstruction; Vascularized free fibula flap

Mesh:

Year:  2015        PMID: 26602741     DOI: 10.1016/j.bjps.2015.10.007

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  6 in total

1.  Fibula Free Flap in Head and Neck Reconstruction: Identifying Risk Factors for Flap Failure and Analysis of Postoperative Complications in a Low Volume Setting.

Authors:  Pieter-Jan Verhelst; Flore Dons; Pieter-Jan Van Bever; Joseph Schoenaers; Lloyd Nanhekhan; Constantinus Politis
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2018-06-05

Review 2.  Scaffolds and coatings for bone regeneration.

Authors:  Helena Filipa Pereira; Ibrahim Fatih Cengiz; Filipe Samuel Silva; Rui Luís Reis; Joaquim Miguel Oliveira
Journal:  J Mater Sci Mater Med       Date:  2020-03-02       Impact factor: 3.896

3.  Lumbopelvic shortening and local host bone-to-host bone reconstruction: a surgical method for lumbopelvic fusion following total sacrectomy.

Authors:  Ahmed Cherry; Colby Oitment; Jay Wunder; Peter Ferguson; Raja Rampersaud
Journal:  Eur Spine J       Date:  2022-09-03       Impact factor: 2.721

4.  Effects of a self-assembling peptide as a scaffold on bone formation in a defect.

Authors:  Kei Ando; Shiro Imagama; Kazuyoshi Kobayashi; Kenyu Ito; Mikito Tsushima; Masayoshi Morozumi; Satoshi Tanaka; Masaaki Machino; Kyotaro Ota; Koji Nishida; Yoshihiro Nishida; Naoki Ishiguro
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

5.  Osteocutaneous flaps for head and neck reconstruction: A focused evaluation of donor site morbidity and patient reported outcome measures in different reconstruction options.

Authors:  Marie Kearns; Panagiotis Ermogenous; Simon Myers; Ali Mahmoud Ghanem
Journal:  Arch Plast Surg       Date:  2018-11-15

6.  Good functional outcome evaluation of free vascularized fibular head graft (FVFHG) as treatment after resection of giant cell tumor (GCT) campanacci 3 at proximal humerus: A case report.

Authors:  Ruksal Saleh; Henry Yurianto; Padlan Pasallo; Astrawinata Guatama; Erich S Subagio
Journal:  Int J Surg Case Rep       Date:  2019-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.